Literature DB >> 29501309

The use of laryngeal mask airway for adenoidectomy.

Nickolas Boroda1, Monika Malesinska2, Michelle S Kars2, Lee P Smith3.   

Abstract

OBJECTIVES: Airway management during adenoidectomy is traditionally performed through endotracheal intubation (ETT). Laryngeal mask airway (LMA) may be less stimulating to the airway and allow for shorter overall operating room time. Previous studies report LMA use during adenotonsillectomy. There has been no prior evaluation of LMA use during adenoidectomy alone. In this study, we attempt to identify the rate and contributing factors of LMA failure during adenoidectomy.
METHODS: All pediatric patients undergoing adenoidectomy between January 1, 2016 and June 30, 2017 were reviewed. Demographic and clinical data were collected and analyzed to determine the need for conversion to ETT and the occurrence of any complications.
RESULTS: Our study revealed 139 pediatric patients who underwent adenoidectomy during the study period. 110 patients had adenoidectomy performed with LMA and 27 patients had ETT. Two patients (1.8%) required conversion to ETT because of difficulty with ventilation when the mouth gag was in place. There were no complications. Mean operating room time was 20 min less in the LMA group (P < 0.05).
CONCLUSIONS: The use of an LMA in adenoidectomy may be a safe and effective alternative to ETT. More study is required to determine overall complication rates.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adenoid; Adenoidectomy; Airway; LMA; Laryngeal; Mask

Mesh:

Year:  2018        PMID: 29501309     DOI: 10.1016/j.ijporl.2018.01.034

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  1 in total

1.  Hemodynamics and anesthetic effect of propofol combined with remifentanil in patients undergoing laparoscopic ovarian cystectomy under laryngeal mask airway anesthesia.

Authors:  Yanshu Xu; Jiang Wu; Jili Zhao; Haiping Zhang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.